» Authors » Pieter J Hoekstra

Pieter J Hoekstra

Explore the profile of Pieter J Hoekstra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 312
Citations 7950
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruinsma E, de Bildt A, Hoekstra P, de Kuijper G, van den Hoofdakker B
J Appl Res Intellect Disabil . 2025 Feb; 38(1):e70023. PMID: 39988456
Background: We aimed to identify key factors in implementing and adhering to positive behaviour support (PBS), provided by frontline staff, targeting challenging behaviours of people with intellectual disabilities living in...
2.
Psyllou C, Luman M, van den Hoofdakker B, Van der Oord S, Aghebati A, Boyer B, et al.
J Child Psychol Psychiatry . 2025 Feb; PMID: 39910778
Background: Understanding the mechanisms of change and between-family differences in behavioural parenting interventions for children with attention-deficit/hyperactivity disorder (ADHD) may help personalise interventions. Therefore, we examined whether improvements in parenting...
3.
Saracaydin G, van Rooij D, Kleine-Deters R, Messchendorp M, Naaijen J, Penzol M, et al.
Eur Child Adolesc Psychiatry . 2025 Jan; PMID: 39825936
While impaired response inhibition has been reported in attention-deficit/hyperactivity disorder (ADHD), findings in disruptive behavior disorders (DBDs) have been inconsistent, probably due to unaccounted effects of co-occurring ADHD in DBD....
4.
5.
Rosenau P, Dietrich A, van den Hoofdakker B, Hoekstra P
Eur Child Adolesc Psychiatry . 2024 Nov; PMID: 39601808
Attention-deficit/hyperactivity (ADHD) guidelines recommend that the need for continued stimulant medication treatment of children and adolescents needs to be reviewed at least annually. We aimed to assess the outcomes in...
6.
van der Pal Z, Geurts H, Haslbeck J, van Keeken A, Bruijn A, Douw L, et al.
Eur Child Adolesc Psychiatry . 2024 Nov; PMID: 39527154
Stimulant medication is effective in alleviating overall symptom severity of attention-deficit/hyperactivity disorder (ADHD), yet interindividual variability in treatment response and tolerability still exists. While network analysis has identified differences in...
7.
Garcia-Marin L, Campos A, Diaz-Torres S, Rabinowitz J, Ceja Z, Mitchell B, et al.
Nat Genet . 2024 Oct; 56(11):2333-2344. PMID: 39433889
Subcortical brain structures are involved in developmental, psychiatric and neurological disorders. Here we performed genome-wide association studies meta-analyses of intracranial and nine subcortical brain volumes (brainstem, caudate nucleus, putamen, hippocampus,...
8.
van Oers H, Alrouh H, Tieskens J, Luijten M, de Groot R, Broek E, et al.
JCPP Adv . 2024 Oct; 4(3):e12213. PMID: 39411480
Background: The COVID-19 pandemic negatively affected child and adolescent mental health and at the end of the pandemic (April 2022) child mental health had not returned to pre-pandemic levels. We...
9.
Garcia-Marin L, Campos A, Diaz-Torres S, Rabinowitz J, Ceja Z, Mitchell B, et al.
medRxiv . 2024 Oct; PMID: 39371125
Subcortical brain structures are involved in developmental, psychiatric and neurological disorders. We performed GWAS meta-analyses of intracranial and nine subcortical brain volumes (brainstem, caudate nucleus, putamen, hippocampus, globus pallidus, thalamus,...
10.
Kiernan C, Dijk H, van den Hoofdakker B, Hoekstra P, Groenman A
J Child Psychol Psychiatry . 2024 Sep; 66(3):289-300. PMID: 39344292
Background: Economic evaluations of treatments for children with behavioural difficulties (i.e., characteristics of attention-deficit/hyperactivity disorder (ADHD) and/or oppositional defiant disorder (ODD)) usually rely on data of randomised controlled trials or...